defer us trials until cashflow, page-35

Oh resourced, I have been nothing but open and honest on these threads and certainly don't need you to try and twist what is being said to make me out to be hunting for cheaper simply because I sold out. I have shared many hours of research and information on here over the years and have spoken out when I didn't think the deal was right for an increase in sp and when I did buy back a small amount the regulatory pathway opened up to be much bigger and longer, so I sold them also knowing what that would involve.

It doesn't mean that I don't take a great interest in what they do as I am very interested. I had post at the time that a CR was needed due to $17m being needed for trials alone, they should raise this and not wait over a year to get them going. A raise after EMA approval will only hurt holders again as the market will know they are coming for it, check out the ACL debarcle that occured when they delayed trials for the Fonda approval, the market smashed them knowing they needed funding after, it was as iff they hadn't received FDA approval.

So please, don't try and tell me doing the trials now would suit me but not you, your wanting them to sit idle until approval so that you may get out at higher prices are you not? Will you hang around after approval knowing they wont earn much money for the first year and are in great need of funding?